deltatrials
Completed NA INTERVENTIONAL 1-arm NCT04070144

The First Puncture Success Rate of a Novel Injeq IQ-Tip™ System in Pediatric Lumbar Punctures (IQ-LP-03)

Sponsor: Injeq Ltd

Interventions IQ-Tip(tm) system
Updated 8 times since 2019 Last updated: Jun 12, 2023 Started: Nov 8, 2019 Primary completion: Aug 6, 2020 Completion: Oct 2, 2020
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04070144, this NA trial focuses on Lumbar Puncture and remains completed. Sponsored by Injeq Ltd, it has been updated 8 times since 2019, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Sep 2019 – ~Dec 2019 · 3 months · monthly snapshotNot Yet Recruiting~Dec 2019 – ~Sep 2020 · 9 months · monthly snapshotRecruiting~Sep 2020 – ~Jan 2021 · 4 months · monthly snapshotActive Not Recruiting~Jan 2021 – ~Nov 2022 · 22 months · monthly snapshotActive Not Recruiting~Nov 2022 – ~Jul 2023 · 8 months · monthly snapshotUnknown Status~Jul 2023 – ~Jul 2024 · 12 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 24 months · monthly snapshotCompleted

Change History

8 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. Jul 2023 — Jul 2024 [monthly]

    Completed NA

    Status: Unknown StatusCompleted

  4. Nov 2022 — Jul 2023 [monthly]

    Unknown Status NA

    Status: Active Not RecruitingUnknown Status

  5. Jan 2021 — Nov 2022 [monthly]

    Active Not Recruiting NA

Show 3 earlier versions
  1. Sep 2020 — Jan 2021 [monthly]

    Active Not Recruiting NA

    Status: RecruitingActive Not Recruiting

  2. Dec 2019 — Sep 2020 [monthly]

    Recruiting NA

    Status: Not Yet RecruitingRecruiting

  3. Sep 2019 — Dec 2019 [monthly]

    Not Yet Recruiting NA

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Injeq Ltd
Data source: Injeq Ltd

For direct contact, visit the study record on ClinicalTrials.gov .